subscribe
 

Advances in Recombinant Protein Technologies

ELRIG have announced that registration is now open for its Advances in Recombinant Protein Technologies which this year will focus on redesigned synthetic systems. The 2 day symposium will be held at the Astra Zeneca’s Alderley Park Site...

A new player in brain disease and stroke

Research that shows how cells respond to brain damage may lead to a new treatment for stroke and neurodegenerative diseases.

Rising CO2 Levels: Not a toothless threat

Rising carbon dioxide levels in the atmosphere are having a catastrophic effect on microscopic marine life, according to top marine scientists at the University of St Andrews.

Mobile phone runs on urine power

Scientists working at the Bristol Robotics Laboratory, which is a collaboration between the University of the West of England (UWE Bristol) and the University of Bristol, have developed a novel way of charging mobile phones using urine as...

Measles virus improves radiotherapy treatment

An innovative new combination treatment that uses the measles virus to target cancer cells could significantly improve treatment for bowel and head & neck cancer, new research suggests.

New hope in the fight against childhood cancer

Cancer Research UK scientists at the University of Southampton are seeing positive results in a pre-clinical trial that could bring treatments for a particular aggressive form of childhood cancer closer to reality.

Southampton engineers develop novel method to increase lifespan of joint replacements

Researchers at the University of Southampton have completed a project that will enable surgeons to fit joint replacements with longer, optimised lifespans.

Protecting drinking water systems from deliberate contamination

An international project has developed a response programme for rapidly restoring the use of drinking water networks following a deliberate contamination event.

Low levels of toxic proteins linked to brain diseases, study suggests

Neurodegenerative diseases such as Alzheimer's could be better understood thanks to insight into proteins linked to such conditions, a study suggests.

Retina implant AG’s Alpha IMS wins CE mark

Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), has announced that its...

RAME-HART helps veterinary manufacturers in emerging markets

RAME-HART, a leading global supplier of advanced automated egg inoculating and harvesting technologies, is helping veterinary manufacturers develop high quality and effective vaccines with a semi-automatic line of technologies that are...

Exotic fish study sheds light on how our nerves protect themselves

Fresh insights gained from a study of tropical fish could help our understanding of how the nervous system works.

Are solariums eight times more effective than natural sunlight?

Vitamin D is one of the key building blocks of the human immune system and the importance of vitamin D for bone density has long been recognised. A growing number of studies have shown that high levels of vitamin D can also help to combat...

ClinTec International launches master's degree

ClinTec International hosts Lord Provost Sadie Docherty at Glasgow HQ as CRO formally launches master’s degree.

Curie-Cancer and Sanofi cooperate in research on ovarian cancer

Sanofi and the Curie Institute, through its Curie-Cancer partnership under the Institut Carnot label, have announced the establishment of a three-year research collaboration to identify new therapeutic targets for the development of...

Obesity increases the risk of preterm delivery

The risk of preterm delivery increases with maternal overweight and obesity, according to a new Swedish study published in Journal of the American Medical Association (JAMA).

Join Lonza’s free webinar on convenient and efficient non-viral iPSC generation

The first webinar is scheduled for 18 June 2013 at 10 AM CEST (Berlin). The second session will be held on 19 June 2013 at 2 PM EDT (New York).

Cobra Biologics and Novolytics unveil successful development of bacteriophages against bacterial infection

Cobra Biologics and Novolytics have announced a breakthrough in the development of two Staphylococcus aureus based phage products for Phase I clinical trials with a 100 fold increase in upstream process yields.

Plasticell Ltd and Progenitor Labs join thriving community at SBC

Stevenage Bioscience Catalyst (SBC), the UK’s first open innovation bioscience campus, is pleased to welcome regenerative medicine companies Plasticell Ltd and Progenitor Labs as tenants.

Study reveals significant leakage of carbon stored on land to rivers, lakes, estuaries and coastal regions

New research suggests that human activity could be increasing the movement of carbon from land to rivers, estuaries and the coastal zone

Pages

Newsbrief

Twitter Icon © Setform Limited
subscribe